Programmdetails - 91. Jahrestagung der Deutschen Gesellschaft für Kardiologie

Postervorträge

Update entzündliche Herzerkrankungen

Samstag, 26. April | 10:00 - 11:00 | Posterbereich 15

Vorsitz/Chair: Philipp Ehlermann (Heidelberg), Karin Klingel (Tübingen)

Agenda

(P1858)
Utilizing a novel ADAM10 inhibitory peptide to enhance recovery and reduce IL-1-driven inflammation after myocardial infarction
E. Klapproth (Dresden), J. Marks (Dresden), P. Leubauer (Dresden), C. Prince (Lansing), K. Lorenz (Würzburg), P. Saftig (Kiel), A. El-Armouche (Dresden)
(P1859)
Early diagnosis of infectious endocarditis improves outcomes in men
S. Andreß (Ulm), K. Reischmann (Ulm), S. Markovic (Ehingen (Donau)), F. Rohlmann (Ulm), B. Hay (Ulm), W. Rottbauer (Ulm), D. Buckert (Ulm), S. d´Almeida (Ulm)
(P1860)
Loeffler Endo(myo)carditis: Clinical Characteristics and Outcomes from a Tertiary Center Case Series
P. Buske (Leipzig), J. Jozwiak-Nozdrzykowska (Leipzig), C. Krieghoff (Leipzig), M. Gutberlet (Leipzig), M. Sandri (Leipzig), H. Thiele (Leipzig)
(P1861)
Virulence Potential of Valvular Tissue Debris after Transcatheter Aortic Valve Implantation
K. Kirsch (Leipzig), A. Oberbach (Leipzig)
(P1862)
Cardiac involvement in SARS-CoV-2 infection
C. Gross (Hannover), A. Pavlou (Hannover), S. Chatterjee (Hannover), B. Nilsson-Payant (Hannover), L. M. Busker (Hannover), F. Moeselaken (Hannover), K. Hülskotter (Hannover), H. Kefalakes (Hannover), S. Clever (Hannover), M. von Köckritz-Blickwede (Hannover), S. Perlman (Iowa), A. Volz (Hannover), C. Bär (Hannover), W. Baumgärtner (Hannover), T. Thum (Hannover), T. Pietschmann (Hannover), U. Kalinke (Hannover), J. Bauersachs (Hannover), G. Amanakis (Hannover)
(P1863)
Prognostic significance of the secreted matricellular protein CCN1 for the development of ARDS and 30-day mortality in COVID-19 patients
R. Liehr (Bad Nauheim), O. Miljukov (Würzburg), C. W. Hamm (Gießen), C. Troidl (Gießen), S. T. Sossalla (Gießen), T. Keller (Bad Nauheim), R. Klingenberg (Frankfurt am Main)
(P1864)
Possible implication of miRNAs in the treatment of transcriptionally active erythroparvovirus infection
G. Aleshcheva (Berlin), C. Baumeier (Berlin), F. Escher (Berlin), H.-P. Schultheiss (Berlin)